Aetion
Healthcare AI
Real-world evidence (RWE) analytics
Acquired
Aetion is a healthcare technology company focused on real-world evidence (RWE) and analytics for biopharmaceutical companies, medical device manufacturers, payers, and regulators. Its platform uses causal inference, epidemiologic methods, and AI to turn healthcare data into evidence on treatment safety, effectiveness, and value. In May 2025, Datavant announced an agreement to acquire Aetion, and Aetion has been described as a leader in RWE technology and analytics.
Company Details
- Website
- aetion.com
- Headquarters
- New York, New York, USA
- Founded
- 2013
- Funding
- $212M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring